Global Orthokeratology Industry Gears Up for US$ 88.7 Million Milestone, Fuelled by a Striking 7.3% CAGR by 2028 | Insights by FMI Analysis

The Global Orthokeratology Industry is on the cusp of a substantial growth trajectory, with a projected valuation of US$ 58.1 million in 2022, expected to surge to an impressive US$ 88.7 million by 2028. This remarkable expansion reflects a notable Compound Annual Growth Rate (CAGR) of 7.3% during the period from 2022 to 2028.

Global Orthokeratology Industry is driven by several pivotal factors, including:

Advancements in implantable vision correction techniques, reinforced by evolving regulatory frameworks and increased reimbursement for corrective procedures, aligning with industry standards.
Escalating prevalence of myopia and chronic eye conditions, notably diabetic retinopathy.
Increasing patient awareness about Ortho-K through online channels, coupled with a noteworthy improvement in the success rates of orthokeratology lenses in recent years.
An increasing emphasis on promoting healthy lifestyles, affording individuals greater opportunities for well-being.

Request a Sample of this Report Now!
https://www.futuremarketinsigh....ts.com/reports/sampl

Additionally, the high prevalence of chronic diseases like diabetic retinopathy is expected to positively influence the market prospects. Developments such as the emergence of ingenious orthokeratology products and implantable intraocular lenses will bolster the future possibilities for the Global Orthokeratology Industry.

Though the Global Orthokeratology Industry looks forward to an overall healthy future market prospects, it is not without its share of restraints. The high initial cost of orthokeratology lenses, increasing cases of corneal infection in pediatric patients, less market penetration of the product along a lack of skilled professionals are factors that may subdue the growth of the Global Orthokeratology Industry over the forecast period.